{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:26:07Z","timestamp":1772328367170,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto (FI)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pirkanmaan sairaanhoitopiiri (FI)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10552-016-0737-2","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T05:37:38Z","timestamp":1459489058000},"page":"637-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case\u2013control study"],"prefix":"10.1007","volume":"27","author":[{"given":"Jukka K.","family":"Salminen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teuvo L. J.","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu J.","family":"Murtola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"737_CR1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19:1893\u20131907","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"737_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer Statistics, 2010. CA Cancer J Clin 60:277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"737_CR3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","volume":"45","author":"S Eyal","year":"2004","unstructured":"Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M (2004) The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45:737\u2013744","journal-title":"Epilepsia"},{"key":"737_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/1-4020-5466-1_9","volume":"41","author":"K Batta","year":"2007","unstructured":"Batta K, Das C, Gadad S, Shandilya J, Kundu TK (2007) Reversible acetylation of non histone proteins: role in cellular function and disease. Subcell Biochem 41:193\u2013212","journal-title":"Subcell Biochem"},{"key":"737_CR5","first-page":"1293","volume":"32","author":"F Iacopino","year":"2008","unstructured":"Iacopino F, Urbano R, Graziani G, Muzi A, Navarra R, Sica G (2008) Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells. Int J Oncol 32:1293\u20131303","journal-title":"Int J Oncol"},{"key":"737_CR6","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","volume":"66","author":"Q Xia","year":"2006","unstructured":"Xia Q, Sung J, Chowdhury W, Chen CL, Hoti N, Shabbeer S, Carducci M, Rodriguez R (2006) Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res 66:7237\u20137244","journal-title":"Cancer Res"},{"key":"737_CR7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pros.20587","volume":"67","author":"S Shabbeer","year":"2007","unstructured":"Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA (2007) Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Prostate 67:1099\u20131110","journal-title":"Prostate"},{"key":"737_CR8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/carcin\/bgt019","volume":"34","author":"D Witt","year":"2012","unstructured":"Witt D, Burfeind P, von Hardenberg S, Opitz L, Salinas-Riester G, Bremmer F, Schweyer S, Thelen P, Neesen J, Kaulfuss S (2012) Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2. Carcinogenesis 34:1115\u20131124","journal-title":"Carcinogenesis"},{"key":"737_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0b013e32834a7e6f","volume":"21","author":"M Stettner","year":"2012","unstructured":"Stettner M, Kramer G, Strauss A, Kvitkina T, Ohle S, Kieseier BC, Thelen P (2012) Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. Eur J Cancer Prev 21:55\u201364","journal-title":"Eur J Cancer Prev"},{"key":"737_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0404.2011.01607.x","volume":"125","author":"G Singh","year":"2012","unstructured":"Singh G, Bell GS, Driever PH, Sander JW (2012) Cancer risk in people with epilepsy using valproate-sodium. Acta Neurol Scand 125:234\u2013240","journal-title":"Acta Neurol Scand"},{"key":"737_CR11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/cncr.28479","volume":"120","author":"H Kang","year":"2014","unstructured":"Kang H, Gillespie TW, Goodman M, Brodie SA, Brandes M, Ribeiro M, Ramalingam SS, Shin DM, Khuri FR, Brandes JC (2014) Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer. Cancer 120:1394\u20131400","journal-title":"Cancer"},{"key":"737_CR12","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1158\/1055-9965.EPI-08-0646","volume":"18","author":"J Hallas","year":"2009","unstructured":"Hallas J, Friis S, Bjerrum L, Stovring H, Narverud SF, Heyerdahl T, Gronbaek K, Andersen M (2009) Cancer risk in long-term users of valproate: a population-based case\u2013control study. Cancer Epidemiol Biomark Prev 18:1714\u20131719","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"737_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/02841869409098430","volume":"33","author":"L Teppo","year":"1994","unstructured":"Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Acta Oncol 33:365\u2013369","journal-title":"Acta Oncol"},{"key":"737_CR14","unstructured":"Martikainen J, Rajaniemi S (2002) Drug reimbursement systems in EU member states, Iceland and Norway. The Social Insurance Institution, Finland, Social security and health reports 54, 2002, Helsinki, Finland. http:\/\/www.kela.fi\/web\/en\/reimbursements-for-medicine-expences"},{"key":"737_CR15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516\u2013524","journal-title":"J Am Stat Assoc"},{"key":"737_CR16","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.lfs.2005.01.003","volume":"76","author":"AS Beutler","year":"2005","unstructured":"Beutler AS, Li S, Nicol R, Walsh MJ (2005) Carbamazepine is an inhibitor of histone deacetylases. Life Sci 76:3107\u20133115","journal-title":"Life Sci"},{"key":"737_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/bmj.325.7371.1013","volume":"325","author":"DC Heaney","year":"2002","unstructured":"Heaney DC, MacDonald BK, Everitt A, Stevenson S, Leonardi GS, Wilkinson P, Sander JW (2002) Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 325:1013\u20131016","journal-title":"BMJ"},{"key":"737_CR18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/epi.12763","volume":"55","author":"S Steer","year":"2014","unstructured":"Steer S, Pickrell WO, Kerr MP, Thomas RH (2014) Epilepsy prevalence and socioeconomic deprivation in England. Epilepsia 55:1634\u20131641","journal-title":"Epilepsia"},{"key":"737_CR19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.10749","volume":"102","author":"E Pukkala","year":"2002","unstructured":"Pukkala E, Weiderpass E (2002) Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971\u201395. Int J Cancer 102:643\u2013648","journal-title":"Int J Cancer"},{"key":"737_CR20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/aje\/kwm069","volume":"166","author":"R M\u00e5nsson","year":"2007","unstructured":"M\u00e5nsson R, Joffe MM, Sun W, Hennessy S (2007) On the estimation and use of propensity scores in case\u2013control and case-cohort studies. Am J Epidemiol 166:332\u2013339","journal-title":"Am J Epidemiol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-016-0737-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0737-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:04:25Z","timestamp":1559221465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-016-0737-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1007\/s10552-016-0737-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}